Amgen is currently testing a new GnRH antagonist, Abarelix, for endo.
My name is Mandi Hood. As I sit and write this I am recovering from a hysterectomy on October 2, 2002. I am 32 and was diagnosed with Endometriosis at 21. I have had 12 surgeries in the last 11 years. I almost feel like an expert now. I had Endometriosis, polycystic ovaries, and fibrocystic tumors. I so wanted a child so when the doctors told me to have a hysterectomy at 21 I told them no that my God was bigger than them and they were not removing any of my body parts… thus begins my long journey.
After many fertility treatments, Lupron treatments, and many other treatments, I did eventually lose my left ovary and fallopian tube in January 2000 because of a cyst the size of an orange. Every surgery brought more bad news of scar tissue and Endometriosis. My uterus was always stuck to my endometrial wall as well as my ovaries. I also had Endometriosis on my colon and no doctor dared to touch that. Pain has been my constant companion for all of these years. I was diagnosed with fibromyalgia in August 1999. I had no idea the two were related until now.
In August 2000, after giving up hope I found out I was pregnant. My husband, Edward and I now have a beautiful 18 month old baby girl. She is my miracle. Last month I started my period and it was awful. I was bleeding so heavy and passing large clots(4inches in diameter). I had to wear adult diapers. After two weeks of bleeding like this we did another surgery. By the time I got to the hospital my blood count was down to 9. When they got inside they found horrendous scar tissue. My uterus and colon were completely fused together and once again I had fibroids in my uterus. I started bleeding and lost 900cc more blood. I had to have a transfusion. The first few days after surgery I was in so much pain that I swore that if I died and went to hell that Satan would used a hysterectomy as my eternal punishment. Now 9 days later I look at my little girl and thank God for her and for my life. I needed to share my story to let other with this condition know there is hope.
Copyright © 2002. Mandi Hood. All Rights Reserved.
This article talks about whether or not the excision of endometriosis is the best treatment for the disease.
There may be some changes being made as to what instruments are used during laproscopic surgery. This is what an article on Ob.Gyn.News is about.
According to an article on Ob.Gyn.News “Women undergoing an operative hysteroscopy faced a 1.6% risk of uterine perforation in a series of 2,116 surgeries done at a single hospital in France during 1990-2000.”
This story, from Sept 19, 2002, can be found on HealthWorld Online. It is written by LAURAN NEERGAARD, AP Medical Writer.
“SILVER SPRING, Md. (AP) – Thousands of Americans may unwittingly take toxic doses of acetaminophen, putting themselves at risk for serious liver damage, say federal scientists who are debating whether consumers need stiffer warnings about how to safely take the popular over-the-counter painkiller.”
Uncommon Manifestations: Sciatic and Thoracic Endometriosis
As we enter a turning point in healthcare, more physicians are beginning to recognize Endometriosis for the significant issue that it is. Better still, more teens and women with the disease are beginning to advocate for themselves – armed with education and knowledge about Endometriosis, they are becoming partners in their own healthcare and taking an active role in their disease management.
But we still have a long way to go. There are many who still maintain that Endometriosis “can be cured by pregnancy or hysterectomy,” and who believe that the disease only occurs in and on the reproductive organs. Though referred to as “uncommon,” two specific manifestations of the disease are becoming more prevelant. This recognition may be due in part to the practitioner’s increased understanding and awareness of the disease, and/or to the patient’s active role in her own care; speaking up and making herself heard about new or
different symptoms she may be experiencing.
Pelvic Endometriosis is a common gynecological problem. The most common sites are the ovaries, cul-de-sac, uterine tubes, the pelvic peritoneum, the recto-vaginal septum, the cervix and the bowel. Sciatic nerve Endometriosis is less common, but should be included in the diagnosis of pain in the sciatic nerve
The first case of sciatic Endometriosis was described by Denton and Sherill in 1955. Symptoms that may lead to the suspicion of Sciatic Endometriosis include: pain which begins just before menstruation and lasts several days after the end of the flow, motor defecit, low back discomfort radiating to the left leg, left foot drop and weakness, cramping in the left leg when walking for long distances, and tenderness of the sciatic notch. There is generally a previous history of pelvic Endometriosis. If left untreated, the symptoms can lose their cyclical nature with time, due to scarring; resulting in a progressively shorter pain-free interval until constant pain prevails. Early recognition is necessary to prevent permanent damage to the sciatic nerve. The disease may be seen on diagnostic imaging tests in select cases; other cases require visual diagnosis.
Sciatic Endometriosis is generally treated the same way as pelvic disease; surgical eradication and/or a course of medical therapy.
Extensive empirical data discussing this condition exists in peer-reviewed literature. In a 1999 Review of Neurology case report authors Calzada-Sierra, Fermin-Hernandez, Vasallo-Prieto, Gomez-Fernandez and Santana de la Fe discussed a patient with cyclical sciatica due to implantation of endometrial tissue in the sciatic nerve in the region of the sciatic notch. Authors noted, “if it is not treated, a sensomotor mononeuropathy of the sciatic nerve develops.” Their patient had complained of right-sided sciatic pain from the age of 36 years, and over the years a motor deficit had slowly and progressively appeared causing foot drop. The painful crises were related to her menstrual periods. At the age of 44 years, a pyramidal muscle syndrome was diagnosed and treated surgically. This was followed by increase in the crises of sciatic pain. A year later, she
started to have sciatic pain on the left side, which was similar to that of the right side. At the time of publication, the patient was still being treated with depot medroxyprogesterone (Depo Provera), and her pain has disappeared. Authors concluded that “cyclical sciatica due to endometriosis is little known and may lead to permanent disability. Computerized axial tomography of the pelvis using contrast material is very useful for diagnosis. The use of depot medroxyprogesterone seems to be a satisfactory treatment in some patients.”
In a 1999 Fertility & Sterility article, authors Fedele, Bianchi, Raffaelli, Zanconato and Zanette published a study in which they attempted to assess the efficacy and diagnostic value of GnRH agonist (GnRH-a) therapy in cases of hidden sciatic nerve endometriosis. In this case report, authors reviewed the treatment of three patients with cyclic, catamenial (“upon menstruation”) sciatica associated with pelvic endometriosis, who had electromyographic evidence of sciatic nerve damage but negative computed tomography (CT Scan) and
magnetic resonance imaging (MRI) findings. Their patients were given a monthly administration of Lupron plus 25 mcg. of addback. As a result, all three patients had clear decreases in pain and partial amelioration of claudication. Authors concluded that “Endometriosis of the sciatic nerve may be hard to diagnose with the use of current imaging techniques, but may be proved by clinical response to GnRH analogue treatment and may be more frequent than previously thought.”
Another report in a 1996 edition of the journal Spine presented by authors Dhote, Tudoret, Bachmeyer, Legmann and Christoforov outlined a review of a case of cyclic sciatica secondary to ovarian cyst endometriosis. Authors noted that “Endometriosis of the sciatic nerve is rare, but must be included in the differential diagnosis of sciatic mononeuropathies.” The authors reported a case of a patient whose cyclic sciatica was caused by an ovarian cystic endometriosis lesion. Magnetic resonance imaging permitted a specific diagnosis of this unusual cause of sciatica by showing a hemorrhagic mass in the region of the sciatic
nerve. Authors further concluded that “early recognition is necessary to prevent permanent damage to the sciatic nerve.”
In “Endometriosis of the Sciatic Nerve: Case Report Demonstrating the Value of MR Imaging,” authors Descamps et al. stated that “Endometriosis…should be considered in menstruating women in view of the diagnostic strategy and ensuing therapeutic implications.” Authors related a case of sciatic nerve involvement with Endometriosis in contact with the nerve in the left sciatic notch which was discovered by MRI. Authors concluded that “MRI was invaluable for the diagnosis, revealing a signal on the stem of the nerve suggestive of a lesion with haemorrhagic content.”
Hysterectomies may also be indicated as treatment for patients who have completed their families. One such case where a hysterectomy was effective treatment for the patient is presented in “Adenomyosis–an Unusual Cause of Sciatic Pain” by al-Khodairy AT; Gerber BE and Praz G. Authors report the case of “a female patient who presented with a 5-month history of sciatic pain who had been referred for investigation and surgical treatment of a suspected herniated lumbar intervertebral disc. Because of an ill-defined clinical picture at admission, she was treated conservatively. After 2 weeks without any improvement, imaging of the spine by MR (magnetic resonance) was performed. No signs of a herniated disc or intraspinal, space-occupying lesion were apparent, but a right paramedian pelvic mass was seen. Ultrasonography confirmed an enlarged, irregular uterus. Hysterectomy abolished the symptoms.”
An excellent review by Mazin Ellias, M.D., F.R.C.A., Director, Associate Professor, Pain Management Program, Medical College of Wisconsin, entitled “Endometriosis of the Sciatic Nerve” outlines the importance of early diagnosis and detection to prevent permanent sciatic nerve damage. Dr. Ellias states that “physical examination findings may reveal various neurological deficits involving the sciatic nerve rootlets. There may be localized tenderness over the sciatic notch, but this is not classical finding. Pelvic examination may be normal. Hormonal suppression of the endometrial tissue may also cause pain relief and aids in proper diagnosis. CT and MRI findings of endometriosis can be variable as they can appear as solid or complex cystic lesions, and involvement of the sciatic nerve at the sciatic notch has been a constant feature.” Dr. Ellias further
states that “electromyography has been useful in diagnosis as well as differentiating between peripheral and root nerve involvement. However, normal findings on electromyography have been reported. An unequivocal diagnosis can be made by direct visualization during operative surgery/laparoscopy and confirmed by histopathology. The ‘pocket sign’ visualization under laparoscopy or surgery of a peritoneal evagination containing ectopic endometrial tissue has been described by Head et al. In patients with cyclic sciatic pain, this finding may be the only clue to the presence of endometriosis, however this sign may be overlooked by the surgeon.”
Extensive literature exists on findings of thoracic (lung) Endometriosis in patients worldwide, the first of which date back as far as 1912. According to Dr. Andrew Cook, thoracic Endometriosis is divided into two parts: pleural, which is the lining of the lung, and parenchymal, which is the lung itself. The majority of cases occur in the pleura, rather than the lung itself.
Deep chest pain
Pneumothorax (collapsed lung)
Pleural effusion (“water on the lung”)
Bloody sputum occuring with menses
In a recent report, “Catamenial Pneumothorax with Diaphragmatic Endometriosis,” authors Yoshida, Izumi, Hasegawa and Kubota noted the experiences of a 30 year-old patient who had twice presented with pneumothorax that was related to the onset of menstruation. Upon thoracoscopy, the presence of blueberry spots and pinholes in the lateral part of the central tendon in the diaphragm were seen. Histological findings showed Endometriosis of the diaphragm. She was followed without hormonal therapy, but recurrent right
pneumothorax occurred. She was then placed on Lupron for 5 months and remained asymptomatic 7 months after surgery.
In “Catamenial Pneumothorax–Endometriosis as a Multidisciplinary Challenge” by S. Leodolter and W. Marhold, authors noted, “…since the condition is poorly understood, patients with ‘catamenial pneumothorax’ tend to be subjected to often quite stressful surgical procedures. These do not provide a permanent cure, as shown by the presented case. Traditional hormonal regimens are also associated with high relapse rates. Consequently, abdominal hysterectomy with bilateral removal of the adnexa has been the treatment of choice if fertility was no longer desired. The battery of conservative treatment modalities has, however, recently been expanded by the use of GnRH analogues and antigestagens. As embryogenesis and the factors underlying the development of endometriosis are better understood and as the complex symptoms of the condition as well as the state-of-the-art therapeutic approaches are more widely appreciated, women
afflicted with the condition should be able to benefit from a more rational and possibly even causal treatment concept.”
In his 1991 book, “Endometriosis: Contemporary Concepts in Clinical Management,” Dr. Bob Schenkin wrote that “Endometriosis of the lung accounted for all reported cases of Endometriosis which occured outside of the
abdomen. Approximately 100 confirmed cases, and many more suspected cases, have been reported over the years.”
As with Endometriosis in general, it is not definitively known why or how this manifestation of the disease occurs. It is thought, however, that circulating peritoneal fluid encourages endometriotic tissue to implant on the diaphragm. This in turn causes structural damage, such as minute holes, which then allow passage of the tissue into the lining of the lung.
Most patients with thoracic Endometriosis also have pelvic Endometriosis. Thoracic Endometriosis may be suspected based on diagnostic testing and patient symptoms, but surgery is still the gold standard for confirmation of diagnosis. Treatments include medical therapy and surgery.
 “Endometriosis of the Sciatic Nerve” by Mazin Ellias, M.D., F.R.C.A., Director, Associate Professor, Pain Management Program, Medical College of
Wisconsin. Froedtert Memorial Lutheran Hospital/Grand Rounds April/June, 1999: Volume 6, Number 2
 &  “Cyclic sciatica. A manifestation of compression of the sciatic nerve by endometriosis: a case report;” Spine 1996 Oct 1;21(19):2277-9 (ISSN:
0362-2436). Dhote R; Tudoret L; Bachmeyer C; Legmann P; Christoforov B; Service de Medecine Interne, Hopital Cochin, Paris, France.
 “Bilateral Cyclic Sciatica Caused by Endometriosis,” Rev Neuro (Jul 1-15;29(1):34-6, ISSN: 0210-0010), Calzada-Sierra DJ; Fermin-Hernandez E;
Vasallo-Prieto R; Gomez-Fernandez L and Santana de la Fe from the Centro Internacional de Restauracion Neurologica, Ciren, La Habana, Cuba
 “Phantom Endometriosis of the Sciatic Nerve,” Fertil Sterol 1999 Oct;72(4):727-9 (ISSN: 0015-0282) by Feudal L; Blanch S; Raffaelli R;
Zanconato G; Zanette G; Department of Obstetrics and Gynecology, University of Verona, Italy
 “Endometriosis of the Sciatic Nerve: Case Report Demonstrating the Value of MR Imaging,” Eur J Obstet Gynecol Reprod Biol 1995 Feb;58(2):199-202 (ISSN:
0301-2115). Descamps P; Cottier JP; Barre I; Rosset P; Laffont J; Lansac J; Body G, Department of Obstetrics and Gynecology, University Hospital, Tours,
 “Adenomyosis-an Unusual Cause of Sciatic Pain” Eur Spine J 1995;4(5):317-9 (ISSN: 0940-6719). al-Khodairy AT; Gerber BE; Praz G,
Department of Orthopaedic Surgery, Hopital de Pourtales, Neuchatel, Switzerland
 “Ask Dr. Cook,” www.drcook.com  Kyobu Geka 1999 Nov;52(12):1040-2
 Gynakologisch-geburtshilfliche Abetilung, Krankenhaus Lainz, Wien
 “Endometriosis: Contemporary Concepts in Clinical Management,” Robert Schenkin, MD
Copyright © 1999 by Heather C. Guidone. All rights reserved. Do not reproduce without express permission
An article on BBC News from Sept 20, 2002 started out by saying “Women who take hormone replacement therapy long-term are more likely to develop a serious disease than be protected against one, researchers suggest.”
An article that was released in Febrtuary of 2002, stated that “A woman has more than five times the normal risk of developing endometriosis if her sister has the disease, according to research published today (Thursday 28 February) in Europe’s leading reproductive medicine journal, Human Reproduction*.”
The full article can be found at SciTecLibrary.
I apologise for the delay in posting this article. I did have it saved in my file folder but things were very hectic at that time due to projects and midterms.
House of Representatives Overwhelmingly Supports H. Con. Res. 291 in Session of 107th Congress.
DELRAY BEACH, FL. / October 3, 2002 — The Endometriosis Research Center (ERC) is delighted to announce that House Concurrent Resolution 291 was unanimously passed in the House of Representatives on October 1, 2002.
Introduced by Congressman Buck McKeon (R-25th District) and supported by numerous Co-sponsors, H. Con. Res. 291 officially recognizes the need for
Endometriosis awareness and education, and expresses the sense of Congress that it “strongly supports efforts to raise public awareness of
Endometriosis throughout the medical and lay communities and recognizes the need for better support of patients with Endometriosis, the need for
physicians to better understand the disease, the need for more effective treatments, and ultimately, the need for a cure.”
The ERC, which began working on H. Con. Res. 291 last summer, has been instrumental in other Endometriosis-related legislation as well. Earlier
this year, the ERC celebrated the enactment of Assembly Concurrent Resolution 160, which was unanimously passed by the California State Senate
in March. Introduced by Assemblyman George Runner (R-36th District) and Assemblywoman Patricia Bates (R-73rd District) and supported by 70
Co-Sponsors, ACR 160 officially proclaimed the month of March as “Endometriosis Awareness Month” in conjunction with the ERC’s anniversary.
The ERC also previously testified before the California State Legislature at the invitation of Assemblyman Dennis Cardoza (D-26th District) on behalf of AB 2820, a consequential bill calling for independent research into the presence of Dioxin, which has been linked to Endometriosis, in feminine
hygiene products and the subsequent risks this toxin poses to women and their children. AB 2820 was approved by majority vote and passed on to the Senate Committee on Health & Human Services.
“We are extremely gratified that the 107th Congress has recognized the significant need for awareness and understanding of this painful disease,” said Michelle E. Marvel, Founder and Executive Director of the ERC. “Those who live with Endometriosis know all too well the negative impact the disease can have on their lives,” she said. “However, outside of the Endometriosis community, awareness is severely lacking. We have found that the disease continues to remain misdiagnosed, misunderstood, and ineffectively treated, despite being one of the most prevalent causes of chronic pain in today’s society. Only though awareness can we increase education about Endometriosis.”
Often referred to as “painful periods,” Endometriosis is more than just killer cramps. With Endometriosis, tissue like the endometrium (tissue
lining the uterus which builds up and sheds each month during menstruation) is found outside the uterus, in other areas of the body. These implants
respond to hormonal commands each month and break down and bleed; however, unlike normal endometrium, these implants have no way of leaving the body. The result is internal bleeding, inflammation of surrounding areas, expression of irritating enzymes, and formation of scar tissue. In
addition, depending on the location of growths, interference with the bowel, bladder, intestines and other areas of the pelvic cavity can occur.
Endometriosis has also been found lodged in the skin and at extrapelvic locations such as the arm, leg and even brain.
Symptoms include pelvic pain with or without menstruation, infertility, miscarriage, ectopic pregnancy, pain during or after intercourse,
gastrointestinal difficulties, fatigue, chronic pain, allergies and other immune system-related dysfunction. Studies have also shown an elevated risk of certain cancers and autoimmune disorders in women with Endometriosis. Though there are several theories, researchers remain unsure as to the specific cause of Endometriosis, and there is currently no definitive cure. The current method of diagnosis is an invasive surgical procedure; however, research is underway concerning non-invasive diagnostics.
The pain from Endometriosis can be so debilitating as to render a woman or teen with the illness unable to carry out her normal routine. Businesses
lose millions of dollars each year in lost productivity and work time because of Endometriosis pain. In addition, the cost of surgery required to
diagnose the disease in each patient alone adds greatly to the financial burden of both consumers and companies. “Yet, many people have never even heard of Endometriosis,” said Mary Prenger, Leader of the ERC’s Legislative Awareness Committee. “In fact, in approaching various Representatives to garner support for both ACR 160 and H. Con. Res. 291, we learned that many
of them were unfamiliar with the disease until the ERC brought it to their attention.”
The ERC is a 501(c)3 non-profit organization that was founded by Executive Director Michelle E. Marvel in early 1997 to address the growing needs of the international Endometriosis community. The ERC helps to improve the quality of life for those with the disease through their International
support and education programs, which include nearly 45 in-person support groups throughout the United States, Canada and the Caribbean, and the
Internet’s largest electronic Endometriosis support group; providing practitioners, patients and all those interested in the disease with extensive educational materials; raising awareness about Endometriosis; working with legislators to facilitate proper funding for Endometriosis research; conducting product focus studies; facilitating patient recruitment and participation in clinical trials and research studies; assisting medical
industry leaders with developmental research and data collection on Endometriosis; much more. The ERC is currently implementing their latest program for Professionals, EndoMED(tm), which is designed to encourage global collaboration and advance the study and treatment of Endometriosis. Unlike similar women’s health organizations, the organization is unique in that it is not fee-based. There is never a cost to participate in the ERC programs. The organization exists solely on the donations and contributions of concerned individuals and organizations that share the ERC’s vision of
helping women and teens with Endometriosis–and of someday finding a cure for the disease.
“With the sponsorship of policymakers like Congressman McKeon and our other supporters, we can ensure that Endometriosis is no longer treated as an insignificant issue,” said Marvel. “Patients, physicians and society at
large need to understand that Endometriosis is a disease which affects all of us.”
The Endometriosis Research Center a 501(c)3 Tax Exempt, Tax Deductible Organization
630 Ibis Drive | Delray Beach, FL 33444 USA
Toll free: 800/239-7280
Direct: 561/274-7442 Fax: 561/274-9117
Email: EndoFL@aol.com | http://www.endocenter.org